Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Army Establishing Medical Technology Enterprise Consortium

by Global Biodefense Staff
March 26, 2015
U.S. Army Medical Research

The U.S. Army Medical Research Acquisition Activity is requesting proposals to organize and operate a Medical Technology Enterprise Consortium (MTEC), a consortium of industrial, academic and other organizations operating as a 501(c)(3) corporation.

The Consortium and its Members shall conduct individual and collaborative efforts to satisfy military requirements, and dual use (military and civilian) requirements where practical.  Collaborating, teaming, and joint ventures among the Consortium members are preferred. The majority of the work for any project shall be executed by the Consortium member or members; it is not to be subcontracted to other organizations.

Activities the Consortium will engage in include:

  • Biomedical research and prototyping
  • Capitalization of private sector technology opportunities
  • Technology transfer
  • Commercialization of Government intellectual property;
  • Follow-on production for the U.S. Army Medical Research Acquisition Activity

The Army expects the Consortium to commercialize the research and products developed in order to generate revenue for further research and development.  Included in this potential revenue stream are items such as royalties from patents generated, revenue from commercial test agreements and test service agreements, revenue generated by prototyping of products, and revenue from Government intellectual property.

Further details are available via Solicitation Number: W81XWH15MTEC. The response deadline is April 13, 2015.

Tags: Request for Proposals

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC